Adeno-Associated Virus (AAV)-based gene therapy vectors are in development for many inherited human disorders. In nonclinical studies, cellular immune responses mediated by cytotoxic T cells may ...
Austin, June 18, 2025 (GLOBE NEWSWIRE) -- ELISpot and Fluorospot Assay Market Size & Growth Analysis: According to SNS Insider, the global ELISpot and Fluorospot Assay Market was valued at USD 290.92 ...
We examined cytomegalovirus-specific cell-mediated immunity (CMV-CMI) to pp65 and IE-1 at 100 days after hematopoietic cell transplantation (HCT) following discontinuation of letermovir prophylaxis ...
Dublin, Feb. 07, 2024 (GLOBE NEWSWIRE) -- The "ELISpot and FluoroSpot Assay Market - Global Forecast to 2028" report has been added to ResearchAndMarkets.com's offering. The global ELISpot and ...
April 3, 2003 — ELISPOT, an enzyme-linked immunospot that detects T cells specific for Mycobacterium tuberculosis antigens, promises to be a major advance in screening for tuberculosis (TB), according ...
The Elispot and Fluorospot Assay Market is witnessing steady growth owing to its vital role in immunological research and clinical diagnostics. These assays offer high sensitivity and specificity in ...
The Elispot and Fluorospot Assay market has emerged as a cornerstone of immunological research, with its precision and ability to measure cellular responses playing a critical role in diagnostic and ...
ProImmune Ltd. has launched the B cell ELISpot assay as a service. The B cell ELISpot assay is central to the characterization of adaptive immune responses to infection, immune modulators, vaccines ...
(MENAFN- GlobeNewsWire - Nasdaq) SNS Insider Unveils Strategic Insights into the U.S. ELISpot and Fluorospot Assay Market's Rapid Growth-Valued at USD 79.68 Million in 2023-While the U.S. Commands ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results